₹ 1.0 Cr
Volume Transacted
(Dec 11, 2024)
16.4 K
Stocks Traded
(Dec 11, 2024)
Last Updated on: Dec 11, 2024
Akums Drugs & Pharmaceuticals Ltd
NSE: AKUMS
YEARHIGH
₹ 1174.85
Last updated on: Dec 11, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
11 Dec 2024 | 612.45 | 612.7 | 615.9 | 608.55 |
10 Dec 2024 | 612.45 | 627 | 628.55 | 608.05 |
09 Dec 2024 | 624.55 | 624.3 | 632.35 | 615.65 |
06 Dec 2024 | 624.35 | 610.4 | 634.9 | 608.5 |
05 Dec 2024 | 609.05 | 612.05 | 617.55 | 606.85 |
04 Dec 2024 | 611.65 | 630 | 630 | 606.2 |
03 Dec 2024 | 623.65 | 625.95 | 632.65 | 611.9 |
02 Dec 2024 | 617.3 | 614.95 | 625.55 | 593.6 |
29 Nov 2024 | 605.4 | 615 | 636.75 | 582.7 |
28 Nov 2024 | 606.45 | 649.25 | 653.05 | 606.45 |
Date | Price (₹) |
---|---|
11 Dec 2024 | 612.45 |
10 Dec 2024 | 612.45 |
09 Dec 2024 | 624.55 |
06 Dec 2024 | 624.35 |
05 Dec 2024 | 609.05 |
04 Dec 2024 | 611.65 |
03 Dec 2024 | 623.65 |
02 Dec 2024 | 617.3 |
29 Nov 2024 | 605.4 |
28 Nov 2024 | 606.45 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Akums Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages
This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...
26 Nov 2024 12:47
Akums Drugs hits life high on inking pact with Caregen
Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...
19 Nov 2024 12:59
Akums Drugs & Pharmaceuticals to conduct board meeting
Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...
06 Nov 2024 15:48
Akums Drugs signs license & distribution agreement with Triple Hair Inc.
Akums Drugs & Pharmaceuticals has entered into a License & Distribution Agreement with Tri...
16 Oct 2024 13:12
Akums Drugs gains on inking distribution agreement with Triple Hair Inc.
Under the terms of the agreement, the company has been granted exclusive rights to further...
16 Oct 2024 11:33
Akums Drugs and Pharma reports turnaround Q1 numbers
Revenue from operations was at Rs 1,019 crore in the quarter ended 30 June 2024, up 5.06% ...
26 Aug 2024 10:50
Unlimited trading starting at just Rs. 249*